AusBiotech has announced a new partnership designed to provide its members with discounted access to Oktopi’s AI-informed platform and to expand the services available through the organisation's Business Solutions Program.
Under the agreement, Oktopi becomes a Business Solutions Program Partner, connecting members across biotechnology, medical technology and health tech with preferential pricing and tailored tools to support medicine development.
AusBiotech CEO Rebekah Cassidy said, "Australia's life sciences sector is built on world-class research, entrepreneurship, innovation, and expertise. Opening doors to help organisations access new tools, knowledge, and capabilities that may accelerate development and commercialisation is critical to maintaining our forward momentum."
She added, "The AusBiotech Business Solutions Program is designed to connect members with providers that seek to service the unique needs of our sector. We are pleased to welcome Oktopi to our growing Program and look forward to supporting our members with access to even more innovative solutions, while delivering meaningful cost savings."
Oktopi describes itself as "the world's first cognitive infrastructure for medicine development," combining an AI-informed knowledge engine, an agentic AI peer reviewer, accredited capability development, and a global community and co-development network to help teams "make higher-quality decisions with greater speed, consistency, and confidence."
Oktopi Co-Founder and CEO Dr Craig Rayner said of the partnership, "We are proud to partner with AusBiotech, who are on the front foot in recognising that AI, used responsibly and built on the right infrastructure, can accelerate the whole Australian biotech ecosystem."
He added, "That is what Oktopi is built for: AI-native infrastructure that amplifies expert teams rather than replacing them, so they make sharper decisions and take more medicines closer to patients."
